AC
MNTA

Athos Capital’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Athos Capital’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-147,500
Closed -$7.74M – 91
2020
Q3 		$7.74M Buy
+147,500
New +$6.11M 3.72% 10

Athos Capital's MNTA Position: Q4 2020 in Review

Athos Capital sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 147,500 shares — an estimated $7.74M sold.

Athos Capital first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $7.74M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Athos Capital reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Athos Capital sold 147,500 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $7.74M.
  • Athos Capital first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Athos Capital's Momenta Pharmaceuticals, Inc. position peaked at $7.74M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Athos Capital's 13F filing for Q4 2020, filed 11 Feb 2021.